S12 Androgen Excess in Women: Challenges from Diagnosis to Management

Program: Symposia
Clinical Session
Friday, April 1, 2016: 4:45 PM-6:15 PM
BR East (BCEC)
Chair:
Ricardo Azziz, MD, MPH, MBA, Georgia Regents University, Augusta, GA

Nothing to Disclose: RA
4:45 PM
Duarte Pignatelli, MD, PhD, Endocrinology, Hospital S João, Porto, Portugal
Nothing to Disclose: DP
5:15 PM
Brian G. Keevil, B.Sc., M.Sc., FRCPath, Clinical Biochemistry, University Hospital of South Manchester, Manchester, United Kingdom
Nothing to Disclose: BGK
5:45 PM
Alessandra Gambineri, MD, Universita' di Bologna, Bologna, Italy
Nothing to Disclose: AG
See more of: Symposia

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire